nervous system
• stimulated release of dopamine in the dorsolateral striatum is reduced as compared with wild-type controls
• non-selective muscarinic agonist oxotremorine-M failed to potentiate the release of dopamine
• the bath application of oxotremorine-M to striatal brain slices results in an enhanced decrease in evoked
dopamine release as measured by CV
|